# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA662211 | B | Inhibition of DNA polymerase | 20 | single protein format | Scientific Literature | |||
2. | ALA658100 | B | Inhibition of DNA polymerase | 19 | assay format | Scientific Literature | |||
3. | ALA682810 | F | Concentration that reduces Friend murine leukemia virus titer by 50% | Mus musculus | 13 | organism-based format | Scientific Literature | ||
4. | ALA690203 | F | Percentage of diphosphates (DP) in the second step of staggered assay mixture from step 1 was incubated with GMP kinase and crude extract of HSV-1 infected HeLa cells over night | 20 | cell-based format | Scientific Literature | |||
5. | ALA690305 | F | Percentage of monophosphates (MP) formed in the first step of staggered assay compound was incubated with HSV-1 thymidine kinase for 4 hr | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
6. | ALA690307 | F | Percentage of monophosphates (MP) in the second step of staggered assay mixture from step 1 was incubated with GMP kinase and crude extract of HSV-1 infected HeLa cells over night | 20 | cell-based format | Scientific Literature | |||
7. | ALA695970 | F | Percentage of triphosphates (TP) in the second step of staggered assay mixture from step 1 was incubated with GMP kinase and crude extract of HSV-1 infected HeLa cells over night | Homo sapiens | 19 | cell-based format | Scientific Literature | ||
8. | ALA695601 | F | Antiviral activity against HSV-1 cell line (concentration required to prevent viral cytopathic effect in half of primary rabbit kidney cell cultures); Not Active at 100 ug/mL | Oryctolagus cuniculus | 1 | organism-based format | Scientific Literature | ||
9. | ALA691503 | F | Antiviral activity against HSV-2 cell line (concentration required to prevent viral cytopathic effect in half of primary rabbit kidney cell cultures); Not Active at 100 ug/mL | Oryctolagus cuniculus | 1 | organism-based format | Scientific Literature | ||
10. | ALA708215 | F | Cytotoxicity was evaluated against L1210 leukemia cell line at 250 ug/disk. | Mus musculus | 1 | cell-based format | Scientific Literature | ||
11. | ALA706301 | F | Cytotoxicity was evaluated against low malignancy line at 250 ug/disk. | 1 | assay format | Scientific Literature | |||
12. | ALA716760 | F | Activity in HIV-l infected MT-4 cells cultures; No activity | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
13. | ALA741866 | F | Inhibitory activity against murine leukemia L1210 cells | Mus musculus | 41 | cell-based format | Scientific Literature | ||
14. | ALA746239 | F | Cytotoxicity was evaluated | Mus musculus | 11 | organism-based format | Scientific Literature | ||
15. | ALA882292 | F | Cytotoxicity was evaluated against PO3 cell line at 250 ug/disk. | Mus musculus | 1 | cell-based format | Scientific Literature | ||
16. | ALA800855 | F | Concentration that reduces Rauscher murine leukemia virus titer by 50% | Mus musculus | 13 | organism-based format | Scientific Literature | ||
17. | ALA798953 | B | Evaluated for the 50% inhibition of bovine-liver S-Adenosyl-homocysteine (AdoHcy) hydrolase; Not applicable | Bos taurus | 12 | assay format | Scientific Literature | ||
18. | ALA800520 | B | Inhibition against bovine-liver S-Adenosyl-homocysteine (AdoHcy) hydrolase | Bos taurus | 12 | assay format | Scientific Literature | ||
19. | ALA800619 | B | Evaluated for the 50% inhibition of S-Adenosyl-homocysteine (AdoHcy) hydrolase L929 lysate from murine L-929 cells | 10 | cell-based format | Scientific Literature | |||
20. | ALA821329 | F | Evaluated for 50% plaque inhibition of vaccinia virus replication in murine L929 cells | Vaccinia virus | 16 | organism-based format | Scientific Literature |